Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral MOA-728 for Opioid-Induced Bowel Dysfunction
NCT00547586Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylnaltrexone in opioid-induced bowel dysfunction (OIBD), sponsored by Valeant Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on NCT00547586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547586.